---
title: "SANA.US (SANA.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/SANA.US/news.md"
symbol: "SANA.US"
name: "SANA.US"
parent: "https://longbridge.com/en/quote/SANA.US.md"
datetime: "2026-05-20T09:45:46.596Z"
locales:
  - [en](https://longbridge.com/en/quote/SANA.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SANA.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SANA.US/news.md)
---

# SANA.US (SANA.US) — Related News

### [Sana Biotechnology Raises $69 Million Through Equity Offering](https://longbridge.com/en/news/286614446.md)
*2026-05-15T20:50:03.000Z*
> Sana Biotechnology, Inc. raised approximately $69 million by selling 21,607,878 shares of common stock under an agreemen

### [Sana Biotechnology (SANA) Receives a Buy from Wedbush](https://longbridge.com/en/news/286278215.md)
*2026-05-13T14:18:40.000Z*
> Wedbush analyst Martin Fan has maintained a Buy rating on Sana Biotechnology (SANA) with a price target of $7.00. Fan, a

### [Sana Biotechnology | 10-Q: FY2026 Q1 Revenue: USD 0](https://longbridge.com/en/news/285990601.md)
*2026-05-11T20:20:22.000Z*
### [Sana Biotechnology | 8-K: FY2026 Q1 Revenue: USD 0](https://longbridge.com/en/news/285989830.md)
*2026-05-11T20:15:32.000Z*
### [MileCell Biotechnology Launches New Corporate Website, Appoints Nianwei Lin, PhD, as CEO and Wayne Vaz as CCO](https://longbridge.com/en/news/285959539.md)
*2026-05-11T14:14:33.000Z*
> MileCell Biotechnology has launched a redesigned corporate website aimed at enhancing user experience for researchers an

### [Sana Biotechnology (SANA) Is Up 6.3% After Mayo-Backed SC451 Diabetes Cell Therapy Collaboration - What's Changed](https://longbridge.com/en/news/283708647.md)
*2026-04-22T18:10:40.000Z*
> Sana Biotechnology (SANA) has risen 6.3% following a collaboration with Mayo Clinic to advance SC451, a pancreatic islet

### [HC Wainwright Issues Positive Estimate for SANA Earnings](https://longbridge.com/en/news/282980953.md)
*2026-04-16T10:27:22.000Z*
> HC Wainwright has raised its Q2 2026 earnings per share estimate for Sana Biotechnology (NASDAQ:SANA) from ($0.13) to ($

### [](https://longbridge.com/en/news/282682379.md)
*2026-04-13T20:18:56.000Z*
> Sana Biotechnology shares are trading higher after the company announced a strategic collaboration with Mayo Clinic to a